Skip to main content

Table 3 Analysis of tumour volumes detected via 7 T in vivo MRI in a CT1258 based in vivo model of prostate cancer

From: Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer

Animal Day 17; Day 22; Day 24;
Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3]
1 5.22 124.02 276.13
(♂, intact)    
2 5.26 71.90 148.58
(♂, intact)    
3 1.61 40.59 66.14
(♂, castrated)    
4 2.12 120.51 39.74
(♂, castrated) 1.03 32.70 69.87
  1. The male animals received 104 MnCl2 labelled cells. The tumour volumes are displayed for the respective days of MRI measurements after subcutaneous injection. In animal 4, tumour masses developed on the left and right abdominal flanks due to incorrect injection of cells.
  2. ♂ = male animal.
\